Target populations were selected for their relevance to anti-tumor immunity (CD8+ T cells, memory CD4+ T cells, and granulocytes), while source populations included vasculature, tumor cells, CAFs, TAMs, and hybrid E/M cells, reflecting key players in tissue architecture and immune regulation. Here, CD4 is linked to neoplasm.